DRW Securities’s Eli Lilly LLY Stock Holding History

DRW Securities’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$368K	Sell	400 -800	-67%	-$811K	0.01%	779
2025 Q4	$1.29M	Sell	1,200 -1,900	-61%	-$1.82M	0.03%	255
2025 Q3	$2.37M	Sell	3,100 -400	-11%	-$298K	0.04%	219
2025 Q2	$2.73M	Buy	+3,500	New	+$2.72M	0.06%	167
2025 Q1	–	Sell	-700	Closed	-$540K	–	704
2024 Q4	$540K	Sell	700 -1,000	-59%	-$828K	0.02%	319
2024 Q3	$1.51M	Buy	1,700 +800	+89%	+$719K	0.04%	219
2024 Q2	$821K	Buy	900 +400	+80%	+$320K	0.03%	272
2024 Q1	$389K	Buy	+500	New	+$356K	0.01%	247

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DRW Securities's LLY Position: Q1 2026 in Review

DRW Securities reduced its Eli Lilly (LLY) stake by 91% in Q1 2026, selling an estimated $4.77M and leaving 459 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #698.

DRW Securities first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $9.1M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

DRW Securities held 459 shares of Eli Lilly worth $422K as of Q1 2026.
DRW Securities sold 4,707 Eli Lilly shares in Q1 2026, an estimated $4.77M.
Eli Lilly made up 0.01% of DRW Securities's portfolio in Q1 2026, its #698 holding.
DRW Securities first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
DRW Securities's Eli Lilly position peaked at $9.1M in Q1 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.